Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart diseaseWenxin Wang, Xuewei Huang, Lihua Zhu et al.|Cell Metabolism|2021Cited by 223
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 DiabetesXu Cheng, Hongliang Li, Ye-Mao Liu et al.|Cell Metabolism|2020Cited by 167
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19Jingjing Cai, Hongliang Li, Haomiao Li et al.|Cell Metabolism|2021Cited by 134
Kidney Function Indicators Predict Adverse Outcomes of COVID-19Ye-Mao Liu, Hongliang Li, Jing Xie et al.|Med|2020Cited by 124
Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac ArrhythmiaZe Chen, Hongliang Li, Feng Zhou et al.|Circulation Research|2021Cited by 102